Empowering Oncologists for Patient-Centered Progress

diagnostic, digital, molecular residual disease, MRD

Pulse of the Oncologist survey reveals trends in cancer diagnostics, digital solutions, care barriers, and the innovations transforming oncology today.

Apr 14^th • 22 mins listen

Enhancing Cancer Treatment Decisions with Ultrasensitive MRD Testing

Quest Diagnostics, Jesus Izaguirre Carbonell, Thoman Slavin, MRD testing, minimal residual testing, precision tool, biomarker, ctDNA, circulating tumor DNA

Dr. Thomas Slavin breaks down how ultrasensitive MRD testing supports better cancer treatment decisions and enables earlier, more personalized interventions.

Jul 7^th • 19 mins listen

ctDNA Breakthroughs in Mesothelioma Care

diagnostic, immunotherapy, imaging

Exploring immunotherapy and ctDNA innovation in mesothelioma, where molecular monitoring may redefine early cancer detection and treatment.

Nov 3^rd • 15 mins listen